Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Philpott

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Molecular Biosystems|August 2, 2011
Bromodomain-peptide displacement assays for interactome mapping and inhibitor discoveryMartin Philpott, Jing Yang, Tony Tumber, et al.
International Forum of Allergy & Rhinology|December 8, 2022
The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection SurveyShyam Ajay Gokani, Ngan Hong Ta, Andreas Espehana, et al.
Communications Biology|January 17, 2025
Enhancing single-cell transcriptomics using interposed anchor oligonucleotide sequencesJianfeng Sun, Martin Philpott, Danson Loi, et al.
Journal of Medicinal Chemistry|December 6, 2013
Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomainFleur M Ferguson, Oleg Fedorov, Apirat Chaikuad, et al.
Epigenetics & Chromatin|August 7, 2014
Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleachingMartin Philpott, Catherine M Rogers, Clarence Yapp, et al.
Journal of Medicinal Chemistry|August 20, 2011
3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligandsDavid S Hewings, Minghua Wang, Martin Philpott, et al.
Epigenetics & Chromatin|July 3, 2021
AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylationDeniz Uğurlu-Çimen, Deniz Odluyurt, Kenan Sevinç, et al.
Nature Chemical Biology|April 10, 2019
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogrammingAyyub Ebrahimi, Kenan Sevinç, Gülben Gürhan Sevinç, et al.
Human Immunology|March 12, 2009
Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohortIvonne Petermann, Claudia Huebner, Brian L Browning, et al.
Medchemcomm|December 19, 2015
The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomainsDuncan Hay, Oleg Fedorov, Panagis Filippakopoulos, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Molecular Biosystems|August 2, 2011
Bromodomain-peptide displacement assays for interactome mapping and inhibitor discoveryMartin Philpott, Jing Yang, Tony Tumber, et al.
International Forum of Allergy & Rhinology|December 8, 2022
The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection SurveyShyam Ajay Gokani, Ngan Hong Ta, Andreas Espehana, et al.
Communications Biology|January 17, 2025
Enhancing single-cell transcriptomics using interposed anchor oligonucleotide sequencesJianfeng Sun, Martin Philpott, Danson Loi, et al.
Journal of Medicinal Chemistry|December 6, 2013
Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomainFleur M Ferguson, Oleg Fedorov, Apirat Chaikuad, et al.
Epigenetics & Chromatin|August 7, 2014
Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleachingMartin Philpott, Catherine M Rogers, Clarence Yapp, et al.
Journal of Medicinal Chemistry|August 20, 2011
3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligandsDavid S Hewings, Minghua Wang, Martin Philpott, et al.
Epigenetics & Chromatin|July 3, 2021
AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylationDeniz Uğurlu-Çimen, Deniz Odluyurt, Kenan Sevinç, et al.
Nature Chemical Biology|April 10, 2019
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogrammingAyyub Ebrahimi, Kenan Sevinç, Gülben Gürhan Sevinç, et al.
Human Immunology|March 12, 2009
Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohortIvonne Petermann, Claudia Huebner, Brian L Browning, et al.
Medchemcomm|December 19, 2015
The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomainsDuncan Hay, Oleg Fedorov, Panagis Filippakopoulos, et al.
Pageof 8